Cancer Diagnostics
Olympus Launches Combined Imaging Mode to Enhance Cancer Detection Capabilities
Olympus Corporation has introduced a new NBI+TXI observation mode for its EVIS X1 endoscopy system that combines two advanced imaging technologies to improve detection and diagnostic accuracy for gastrointestinal and respiratory cancers, addressing Japan's high cancer incidence rates.
Izotropic Corporation Featured in MarketScreener Editorial on AI Applications in Healthcare
Izotropic Corporation's breast cancer imaging technology is highlighted as a promising AI-driven medical advancement with potential to establish new standards in cancer care.
Izotropic Corporation Launches BreastCT.com to Promote Advanced Breast Cancer Detection Technology
Izotropic Corporation has launched BreastCT.com as an educational platform to raise awareness about its dedicated breast CT technology, which aims to improve cancer detection in women with dense breast tissue, potentially transforming breast cancer screening and diagnosis.
Aditxt Inc. Subsidiary Pearsanta Engages Spartan Capital for Planned IPO to Advance Cancer Detection
Aditxt Inc.'s subsidiary Pearsanta, Inc. has taken a significant step towards its Initial Public Offering by appointing Spartan Capital Securities, LLC as the lead underwriter, aiming to enhance early cancer and disease detection technologies.
Aditxt Inc. Subsidiary Pearsanta Advances in DoD-Funded Ovarian Cancer Diagnostic Study
Aditxt Inc.'s subsidiary Pearsanta moves forward in a Department of Defense-funded study for early ovarian cancer detection, highlighting the potential impact on women's health diagnostics.